Apeloa Pharmaceutical Competitors and Similar CompaniesClear all
Apeloa Pharmaceutical's competitors and similar companies include EyePoint Pharmaceuticals and SciClone Pharmaceuticals.
 Apeloa Pharmaceutical Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products. |  EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. |  SciClone Pharmaceuticals SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. | |
Founding Date | Founding Date 1989 | Founding Date 1987 | Founding Date 1989 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations CN HQ | Locations Watertown, US HQ | Locations Foster City, US HQ |
Employees | Employees 7,060 | Employees 8453% increase | Employees 1102% decrease |
Valuation ($) | Valuation ($) 2.7 b | Valuation ($) 617.6 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥9.7b (FY, 2025) | Revenue (est.) $31.4m (FY, 2025) | Revenue (est.) $160.1m (FY, 2016) |
Net income | Net income ¥890.7m (FY, 2025) | Net income ($232m) (FY, 2025) | Net income $30.7m (FY, 2016) |
For sources of this data, please see the company profile
View Company Profiles
EyePoint Pharmaceuticals
HQ
Watertown, US
Employees
84
EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
View companySciClone Pharmaceuticals
HQ
Foster City, US
Employees
110↓ 2% decrease
SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
View company